Windtree Therapeutics files for secondary stock offering [Seeking Alpha]
Windtree Announces Special Late-Breaking Clinical Science Abstract Presentation on Istaroxime at the Technology and Heart Failure Therapeutics Conference
Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company's Oncology Pipeline [Yahoo! Finance]
Windtree Strengthens Global Intellectual Property Portfolio with New Japanese Patent For the Company’s Oncology Pipeline
Windtree Announces the Addition of Leanne Kelly to Its Board of Directors